News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
...
Agomab Therapeutics to Acquire Origo Biopharma
The acquisition strengthens Agomab as a leader in targeting growth factor pathways Origo Biopharma…
Partners - Asabys Partners
bayer
Bayer and Mammoth Biosciences to collaborate on novel gene editing technology
Healthcare · Gene editing
Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s…
Partners - Bayer Hispania S.L
auto test covid
Note from AseBio on recent regulation actions affecting the sale of diagnostics test kits available at pharmacies, during the current covid-19 situation
Coronavirus
AseBio regrets the fact that Spanish manufacturers of SARS-CoV-2 antigen detection tests have not…
imagen AKRN
Amendment for the transition of in vitro diagnostic medical devices (IVDs) to the EU 2017/746 (IVDR)
This amendment aims to extend the scope and timelines for the transition to the new regulation and…
Partners - NAMSA
récord 284 socios
AseBio sees record number of members
The association has more than 284 members, 65.5% of which focus on biotechnology for healthcare,…
illumina
Multiomics is revolutionizing research, here’s why
Learn why research leaders decided to use Multiomics in their work.  
Partners - Illumina
illumina
Introducing Illumina Connected Analytics
Healthcare · Agrifood · Gene editing · International
Analyze, manage, aggregate, and explore data at scale with Illumina Connected Analytics, a…
Partners - Illumina
enero 2022 bcn
BCN HEALTH publishes a study evaluating the influence of disease severity on healthcare costs among hospitalized NAFLD/NASH patients in Spain
BCN HEALTH realizó un estudio retrospectivo basado en los registros de pacientes hospitalizados por…
Partners - BCN Health
foto oryzon
ORYZON announces approval for Serbian arm of PORTICO, vafidemstat’s Phase IIb trial in Borderline Personality Disorder
Healthcare
Serbian arm final deployment in PORTICO. Study already active in Spain, Bulgaria, Germany and USA…
Partners - Oryzon Genomics